Cite
Infante JR, Korn RL, Rosen LS, et al. Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours. Br J Cancer. 2018;118(2):e3doi: 10.1038/bjc.2017.438.
Infante, J. R., Korn, R. L., Rosen, L. S., LoRusso, P., Dychter, S. S., Zhu, J., Maneval, D. C., Jiang, P., Shepard, H. M., Frost, G., Von Hoff, D. D., Borad, M. J., & Ramanathan, R. K. (2018). Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours. British journal of cancer, 118(2), e3. https://doi.org/10.1038/bjc.2017.438
Infante, Jeffrey R, et al. "Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours." British journal of cancer vol. 118,2 (2018): e3. doi: https://doi.org/10.1038/bjc.2017.438
Infante JR, Korn RL, Rosen LS, LoRusso P, Dychter SS, Zhu J, Maneval DC, Jiang P, Shepard HM, Frost G, Von Hoff DD, Borad MJ, Ramanathan RK. Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours. Br J Cancer. 2018 Jan;118(2):e3. doi: 10.1038/bjc.2017.438. PMID: 29361630; PMCID: PMC5785755.
Copy
Download .nbib